老年人糖尿病伴衰弱的干预研究进展

doi:10.3969/j.issn.1003-9198.2021.05.023

摘要/Abstract

中图分类号:

R 587.1

李诗洁, 张亚欣, 马丽娜, 李耘. 老年人糖尿病伴衰弱的干预研究进展[J]. 实用老年医学, 2021, 35(5): 520-523.

[1] FRIED L P, TANGEN C M, WALSTON J, et al. Frailty in older adults: evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sci, 2001, 56(3):M146-M157.
[2] GARCÍA-ESQUINAS E, GRACIANI A, GUALLAR-CASTILLÓN P, et al. Diabetes and risk of frailty and its potential mechanisms: a prospective cohort study of older adults[J]. J Am Med Dir Assoc, 2015, 16(9):748-754.
[3] SAUM K, DIETZENBACH A K, MÜLLER H, et al. Frailty prevalence and 10-year survival in community-dwelling older adults: results from the ESTHER cohort study[J]. Eur J Epidemiol, 2014, 29(3):171-179.
[4] JUNG H, KIM S, AHN S, et al. Prevalence and outcomes of frailty in Korean elderly population: comparisons of a multidimensional frailty index with two phenotype models[J]. PLoS One, 2014, 9(2):e87958.
[5] LI C L, STANAWAY F F, LIN J D, et al. Frailty and health care use among community-dwelling older adults with diabetes: a population-based study[J]. Clin Interv Aging, 2018, 13:2295-2300.
[6] CHHETRI J K, ZHENG Z, XU X, et al. The prevalence and incidence of frailty in pre-diabetic and diabetic community-dwelling older population: results from Beijing longitudinal study of aging II (BLSA-II)[J]. Bmc Geriatr, 2017, 17(1):47-54.
[7] ULLEY J, ABDELHAFIZ A H. Frailty predicts adverse outcomes in older people with diabetes[J]. Practitioner, 2017, 261(1800): 17-20.
[8] MA L. Current situation of frailty screening tools for older adults[J]. J Nutr Health Aging, 2019, 23(1):111-118.
[9] LEROITH D, BIESSELS G J, BRAITHWAITE S S, et al. Treatment of diabetes in older adults: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2019, 104(5):1520-1574.
[10]MORLEY J E, MALMSTROM T K, RODRIGUEZ-MAÑAS L, et al. Frailty, sarcopenia and diabetes[J]. J Am Med Dir Assoc, 2014, 15(12):853-859.
[11]GARCIA D E, ALONSO R J, HERRERA F N, et al. Effect of strength exercise with elastic bands and aerobic exercise in the treatment of frailty of the elderly patient with type 2 diabetes mellitus[J]. Endocrinol Diabetes Nutr, 2019, 66(9):563-570.
[12]THEOU O, STATHOKOSTAS L, ROLAND K P, et al. The effectiveness of exercise interventions for the management of frailty: a systematic review[J]. J Aging Res, 2011. DOI: 10.4061/2011/569194.
[13]FRANKEL J E, BEAN J F, FRONTERA W R. Exercise in the elderly: research and clinical practice[J]. Clin Geriatr Med, 2006, 22(2):239-256.
[14]SINCLAIR A J, ABDELHAFIZ A, DUNNING T, et al. An international position statement on the management of frailty in diabetes mellitus: Summary of Recommendations 2017[J]. J Frailty Aging, 2018, 7(1):10-20.
[15]中国老年医学学会老年内分泌代谢分会,解放军总医院国家老年疾病临床医学研究中心,中国老年糖尿病诊疗措施专家共识编写组. 中国老年2型糖尿病诊疗措施专家共识(2018年版)[J]. 中华内科杂志, 2018, 57(9):626-641.
[16]ABDELHAFIZ A H, SINCLAIR A J. Diabetes, nutrition, and exercise[J]. Clin Geriatr Med, 2015, 31(3):439-451.
[17]American Diabetes Association. 5. Facilitating behavior change and well-being to improve health outcomes: Standards of Medical Care in Diabetes—2020[J]. Diabetes Care 2020, 43(Suppl 1): S48-S65.
[18]IMRAN S A, AGARWAL G, BAJAJ H S, et al. Targets for glycemic control[J]. Can J Diabetes, 2018, 42: S42-S46.
[19]HUANG C, WENG S, TSAI K, et al. Long-term mortality risk after hyperglycemic crisis episodes in geriatric patients with diabetes: a national population-based cohort study[J]. Diabetes Care, 2015, 38(5):746-751.
[20]YANAGITA I, FUJIHARA Y, EDA T, et al. Low glycated hemoglobin level is associated with severity of frailty in Japanese elderly diabetes patients[J]. J Diabetes Invest, 2018, 9(2):419-425.
[21]American Diabetes Association. 12. Older adults: Standards of medical care in diabetes—2020[J]. Diabetes Care, 2020, 43(Suppl 1): S152-S162.
[22]COSENTINO F, GRANT P J, ABOYANS V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD[J]. Eur Heart J, 2020, 41(2):255-323.
[23]International Diabetes Federation. New IDF clinical practice recommendations for managing type 2 diabetes in primary care[J]. Diabetes Res Clin Pract, 2017, 132: 169-170.
[24]中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 38(4):292-344.
[25]FRANCHIN A, MARAN A, BRUTTOMESSO D, et al. The GesTIO protocol experience: safety of a standardized order set for subcutaneous insulin regimen in elderly hospitalized patients[J]. Aging Clin Exp Res, 2017, 29(6):1087-1093.
[26]KHOSLA S, FARR J N, TCHKONIA T, et al. The role of cellular senescence in ageing and endocrine disease[J]. Nat Rev Endocrinol, 2020, 16(5):263-275.
[27]HICKSON L J, LANGHI PRATA L G P, BOBART S A, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease[J]. EBioMedicine, 2019, 47:446-456.
[28]SASAKI T. Sarcopenia, frailty circle and treatment with sodium-glucose cotransporter 2 inhibitors[J]. J Diabetes Invest, 2019, 10(2):193-195.

老年人糖尿病伴衰弱的干预研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	王苏, 赵一璟, 魏晨敏, 陈堃, 曹雯, 王昆, 杨昱. 老年T2DM病人甘油三酯葡萄糖指数与低密度脂蛋白亚型的关系研究[J]. 实用老年医学, 2024, 38(10): 1002-1006.
[2]	顾崇怀, 项学军, 郑元喜, 乔锐, 林松. 达格列净对接受冠状动脉介入治疗的伴有射血分数降低的心力衰竭合并2型糖尿病老年病人疗效观察[J]. 实用老年医学, 2024, 38(10): 1025-1029.
[3]	周潇, 顾荣, 孔小岑, 罗勇, 王蔚萍, 马建华, 李惠琴. 桑枝总生物碱和卡格列净治疗血糖控制不佳的老年2型糖尿病病人的疗效观察[J]. 实用老年医学, 2024, 38(10): 1066-1069.
[4]	刘倩慧, 姚子俊, 何玉立, 徐云凡, 吴军. 老年2型糖尿病合并慢性心力衰竭病人HbA1c水平对心脏结构和功能的影响[J]. 实用老年医学, 2024, 38(5): 491-437.
[5]	刘童君, 赵雅洁, 胡洁玲, 胡洋, 梁伟. 糖代谢异常对血清激活素A水平的影响[J]. 实用老年医学, 2024, 38(5): 495-437.
[6]	杨龙璇, 唐伟. 细胞衰老与2型糖尿病胰岛B细胞功能障碍的研究进展[J]. 实用老年医学, 2024, 38(5): 521-437.
[7]	王金涛, 胡坚. 老年人2型糖尿病与肌少症的关系研究进展[J]. 实用老年医学, 2024, 38(5): 529-437.
[8]	唐源, 邓暑芳, 何咏梅, 戴雨璇, 罗晶. 老年2型糖尿病病人健康素养水平及其与衰弱的相关性[J]. 实用老年医学, 2024, 38(3): 255-259.
[9]	代玲俐, 俞匀. 老年2型糖尿病病人估计肾小球滤过率与胰岛素抵抗及胰岛B细胞功能的相关性研究[J]. 实用老年医学, 2023, 37(12): 1219-1223.
[10]	范婷泳, 袁丽, 杨小玲, 陈茜. Caprini量表评估老年糖尿病病人静脉血栓栓塞症的效果[J]. 实用老年医学, 2023, 37(12): 1233-1237.
[11]	张贺成, 魏苏. 老年2型糖尿病病人血清铁蛋白水平与糖尿病足发生的相关性[J]. 实用老年医学, 2023, 37(11): 1111-1114.
[12]	胡艳, 巫海娣, 王雪菲, 娄青林, 叶青, 顾刘宝, 戴静, 宋小波. 老年2型糖尿病病人糖尿病足风险评分与尿微量白蛋白/肌酐的相关性分析[J]. 实用老年医学, 2023, 37(11): 1134-1137.
[13]	宗前兴, 莫永珍. 老年2型糖尿病健康状态分层框架的应用与研究进展[J]. 实用老年医学, 2023, 37(11): 1170-1175.
[14]	张林英, 梅群超, 张炜琦, 胡一兰. 抗阻训练联合高乳蛋白营养在老年2型糖尿病伴肌少症病人中的应用研究[J]. 实用老年医学, 2023, 37(10): 995-999.
[15]	刘倩慧, 姚子俊, 何玉立, 吴军. SGLT2i对老年糖尿病病人心血管保护机制的研究进展[J]. 实用老年医学, 2023, 37(10): 1064-1068.